Javascript must be enabled to continue!
Mitochondrial STAT3-mediated suppression of apoptosis constrains antimycobacterial immunity
View through CrossRef
SUMMARY
Maintenance of mitochondrial homeostasis is required to balance the host-pathogen interface during
Mycobacterium tuberculosis
(Mtb) infection. Here, we identify the non-canonical TRIM family member Trim14 as a critical regulator of mitochondrial integrity in Mtb-infected macrophages. Specifically, we demonstrate that Trim14 preserves mitochondrial membrane polarization and limits macrophage apoptosis by controlling phosphorylation and mitochondrial targeting of Stat3. When targeted to mitochondria, Stat3 restricts opening of the mitochondrial permeability transition pore, which raises the macrophage threshold for apoptotic commitment.
In vivo
, loss of Trim14 enhances apoptosis of macrophages and dendritic cells, leading to augmented antimycobacterial immunity marked by increased CD8
+
T cell activation and effector function. Together, these findings define a Trim14–mitochondrial Stat3 axis that suppresses host-protective apoptosis during Mtb infection and pinpoint mitochondrial Stat3 as a potential target for therapies aimed at boosting antimycobacterial immunity.
HIGHLIGHTS
Trim14 raises the apoptotic threshold in Mtb-infected macrophages.
Trim14 controls phosphorylation and mitochondrial targeting of Stat3.
Reduced mitochondrial Stat3 promotes mPTP opening and apoptotic commitment.
Trim14 deficiency enhances apoptosis, CD8
+
T cell immunity, and Mtb resistance.
Title: Mitochondrial STAT3-mediated suppression of apoptosis constrains antimycobacterial immunity
Description:
SUMMARY
Maintenance of mitochondrial homeostasis is required to balance the host-pathogen interface during
Mycobacterium tuberculosis
(Mtb) infection.
Here, we identify the non-canonical TRIM family member Trim14 as a critical regulator of mitochondrial integrity in Mtb-infected macrophages.
Specifically, we demonstrate that Trim14 preserves mitochondrial membrane polarization and limits macrophage apoptosis by controlling phosphorylation and mitochondrial targeting of Stat3.
When targeted to mitochondria, Stat3 restricts opening of the mitochondrial permeability transition pore, which raises the macrophage threshold for apoptotic commitment.
In vivo
, loss of Trim14 enhances apoptosis of macrophages and dendritic cells, leading to augmented antimycobacterial immunity marked by increased CD8
+
T cell activation and effector function.
Together, these findings define a Trim14–mitochondrial Stat3 axis that suppresses host-protective apoptosis during Mtb infection and pinpoint mitochondrial Stat3 as a potential target for therapies aimed at boosting antimycobacterial immunity.
HIGHLIGHTS
Trim14 raises the apoptotic threshold in Mtb-infected macrophages.
Trim14 controls phosphorylation and mitochondrial targeting of Stat3.
Reduced mitochondrial Stat3 promotes mPTP opening and apoptotic commitment.
Trim14 deficiency enhances apoptosis, CD8
+
T cell immunity, and Mtb resistance.
Related Results
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract
Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract
STAT3 is involved in the pathogenesis of many malignancies, so we developed an anti-STAT3 VHH (variable region of the heavy chain), SBT-100, that internaliz...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract
Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract
Cancer is often characterized by aberrant gene expression patterns that alter cellular function. Such alterations are commonly caused by the inappropriat...
Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells
Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells
Abstract
BACKGROUND: Interleukin-6 (IL-6) is a multifunctional cytokine that is involved in immune defense and plays an important role in biologic activities of cell...
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Abstract
Abstract 2849
Poster Board II-825
Histone deacetylase inhibitors (HDACi) are emerging as a potential therapy for Multiple Myel...
O18 Molecular crosstalk between PLCγ1 and STAT3 in cutaneous T-cell lymphoma
O18 Molecular crosstalk between PLCγ1 and STAT3 in cutaneous T-cell lymphoma
Abstract
Cutaneous T-cell lymphoma (CTCL) is a non-Hodgkin lymphoma of skin-homing T lymphocytes that is difficult to diagnose and treat due to a high degree of clin...
Abstract 3806: STAT3/STAT5 blockade by WP1066 inhibits ovarian cancer cell proliferation and induces cell death
Abstract 3806: STAT3/STAT5 blockade by WP1066 inhibits ovarian cancer cell proliferation and induces cell death
Abstract
BACKGROUND: Ovarian cancer is the most deadly gynecologic malignancy with 22,240 new cases and 14,030 deaths estimated in 2013. In order to improve the clin...

